Latest Development Pipeline News

DigiCo Infrastructure REIT appoints Michael Juniper as CEO, signaling a strategic push into advanced data centre development amid rising cloud and AI demand. Chris Maher shifts focus to government relations, underscoring regulatory challenges ahead.

African Gold Limited has entered into a binding agreement for acquisition by Montage Gold Corp. in an all-scrip deal valuing African Gold at a significant premium. The transaction aims to combine key Côte d’Ivoire gold assets under one larger entity.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.

Bio-Gene Technology Limited has received a $519,500 R&D tax incentive from the Australian government, supporting its development of innovative bio-insecticides targeting insecticide resistance.

Finbar Group has completed settlement on a prime South Perth development site valued at approximately $187 million, advancing its substantial $1.2 billion project pipeline with a market launch planned for 2026.

Pro Medicus Ltd has delivered a record-breaking FY2025 with revenue soaring nearly 32% and net profit up 39%, driven by landmark contracts and a robust growth pipeline.

Brightstar Resources outlines a bold growth strategy targeting over 200,000 ounces of annual gold production by 2029, leveraging its Western Australian assets and aggressive drilling programs. The company’s recent feasibility studies and acquisitions position it as a rising gold producer in the region.

Charter Hall Group reported solid FY25 results with 7.4% growth in operating earnings per security and upgraded its FY26 earnings guidance to 95 cents, reflecting robust equity inflows and tenant demand. The company also highlighted significant sustainability progress and board changes at its 2025 AGM.

Finbar Group Limited highlights strong sales momentum in 2025, underpinned by a $1.2 billion development pipeline and a buoyant Western Australian apartment market driven by migration and undersupply.

Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.

LGI Limited reported robust FY25 results with a 14% rise in EBITDA and secured six new contracts, positioning the company for a 25-30% EBITDA increase in FY26. Key project completions and expansions underpin this momentum.

LGI Limited reported robust FY25 results, expanding electricity capacity by 44% and increasing EBITDA by 14%, driven by new landfill gas contracts and battery storage projects. The company is well positioned to capitalize on Australia’s renewable energy transition and evolving carbon credit market.